One Stage Versus Two Stage For Periprosthetic Hip And Knee Infection

NCT02734134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 343

Last updated 2026-05-22

No results posted yet for this study

Summary

The purpose of this study is to compare the outcomes of two different treatment options commonly used to manage periprosthetic joint infection (PJI), an infection around the artificial knee or hip.

Conditions

  • Surgical Site Infection

Interventions

PROCEDURE

One-stage exchange joint replacement surgery

PROCEDURE

Two-stage exchange joint replacement surgery

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER
  • Hospital for Special Surgery, New York

    collaborator OTHER
  • Rothman Institute at Thomas Jefferson University

    collaborator UNKNOWN
  • Midwest Orthopaedics Rush University Medical Center

    collaborator UNKNOWN
  • Vanderbilt University

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • University of Iowa

    collaborator OTHER
  • Carilion Clinic

    collaborator OTHER
  • University of Southern California

    collaborator OTHER
  • Ochsner Health System

    collaborator OTHER
  • Cleveland Clinic Florida

    collaborator OTHER
  • University of Utah

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • OrthoCarolina Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Thomas K Fehring, MD · Attending Hip & Knee Surgeon

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-18
Primary Completion
2024-12-31
Completion
2026-01-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02734134 on ClinicalTrials.gov